For many people with knee osteoarthritis, daily life becomes increasingly difficult over time. Activities such as walking, climbing stairs, getting out of a chair, or even standing for long periods can become painful.
As the disease progresses, some people eventually need total knee replacement surgery because other treatments no longer provide enough relief.
Osteoarthritis is the most common form of arthritis and one of the leading causes of disability worldwide. It develops when the smooth cartilage covering the ends of bones gradually wears away.
Without this protective layer, joints become inflamed, painful, and less flexible. The condition is especially common among older adults and people carrying excess body weight.
Doctors have long known that obesity increases the risk of osteoarthritis because extra weight places greater stress on knee joints. However, scientists are increasingly interested in whether certain weight-loss medications might do more than simply help people shed pounds.
A new study published in Regional Anesthesia & Pain Medicine explored this question by examining the long-term effects of GLP-1 receptor agonists. These medications include semaglutide and tirzepatide, drugs that have gained worldwide attention for treating diabetes and obesity.
Researchers used medical records from the TriNetX Global Research Network, one of the world’s largest healthcare databases. They identified adults diagnosed with knee osteoarthritis between 2010 and 2024 and compared those who received GLP-1 medications with similar patients who did not.
The study involved tens of thousands of patients. Some participants received any GLP-1 receptor agonist for one or three years, while others specifically received newer-generation drugs such as semaglutide or tirzepatide.
The researchers then tracked how many patients eventually underwent total knee replacement surgery. This operation is often considered when pain becomes severe and joint damage significantly affects quality of life.
The results showed a clear pattern. People treated with GLP-1 receptor agonists were less likely to need knee replacement surgery. The longer the treatment continued, the greater the apparent benefit. Newer medications produced the strongest results.
By the eight-year follow-up period, patients who had taken semaglutide or tirzepatide for three years showed nearly a five-percentage-point lower risk of knee replacement surgery compared with similar patients who had not received these drugs.
Why might this happen? Weight loss is one obvious explanation. Losing weight reduces pressure on the knees with every step. Even modest weight loss can significantly decrease joint stress. But researchers believe there may be more to the story.
Emerging evidence suggests GLP-1 drugs may have anti-inflammatory properties. Inflammation plays an important role in osteoarthritis and contributes to joint damage and pain.
Some laboratory studies suggest these medications may help protect cartilage and other joint tissues. Clinical studies have also reported reductions in knee pain among people using these therapies.
Despite the promising findings, researchers caution against drawing firm conclusions too soon. This study looked at associations rather than direct cause-and-effect relationships.
Important factors such as exercise habits, physical fitness, frailty, and osteoarthritis severity were not fully available in the database. In addition, prescription records do not confirm whether patients consistently took the medications.
Still, the findings are noteworthy because current treatment options for osteoarthritis are limited. Most available therapies focus on symptom relief rather than slowing disease progression. If future clinical trials confirm that GLP-1 drugs can delay joint deterioration, the impact could be substantial.
The researchers estimate that even a modest reduction in knee replacement rates could translate into thousands of fewer surgeries each year. This could reduce healthcare costs, lower the risk of surgical complications, and improve quality of life for many patients.
If you care about pain, please read studies about how to manage gout with a low-purine diet, and a guide to eating right for arthritis.
For more health information, please see recent studies about the link between processed foods and chronic diseases, and avoid these 8 foods to ease arthritis pain.
Source: TriNetX Global Research Network study published in Regional Anesthesia & Pain Medicine.
